Cytodyn Inc (CYDY)

[All-Bidness]

I've been long for sometime, however that FDA piece started to make me question things. First we have never seen a full data set on any trial, the company only release top line. 2nd, and this is a big one for me, we finished the trials for HIV 3 years ago, and have yet to successfully submit the BLA, we have $87m waiting for us for acceptance, and then revenue on approval, they spent 10 years on these trials, and continually choose to start new trials in any indication they can think of. After Mahboob left, you have to wonder how bad that HIV trial data is, and if we need to re-do the trial. We just say back to back bad trial designs in CD-10 and CD-12, and that was with more seasoned professionals, who really knows what happened with HIV.